Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic stem cell transplantation

Publication | Closed Access

DOI

Citations

References

2008

Year

Zi Yi Lim, Gordon Cook, Peter Johnson, Anne Parker, Mark Zuckerman, D I Marks, Hugh Wiltshire, G J Mufti, Antonio Pagliuca

Leukemia Research

Active Cmv InfectionPcr-based Pre-emptive TherapyTransplantationImmunologyAntiviral TherapyAntiviral ResponseVirologyAntiviral DrugMedicineCell Transplantation